Clinical Trials

Current clinical trials that the Fehlings lab is involved in include:

  • Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect) [ Identifier: NCT01257828]
  • Riluzole in Spinal Cord Injury Study (RISCIS) [ Identifier: NCT01597518]
  • Surgical Versus Nonoperative Treatment of Metastatic Epidural Spinal Cord Compression (MESCC) [ Identifier: NCT00634426]
  • Constraint Induced Movement Therapy (CIMT)- Neuroimaging Predictors of Positive Response to Constraint (OBI_CIMT) [ Identifier: NCT01643109]
  • North American Clinical Trials Network (NACTN) for Treatment of Spinal Cord Injury [ Identifier: NCT00178724]